Aventis Pharmaceuticals Inc. v. Barr Laboratories Inc.
1:06-cv-00286
Overview
Parties
Defendant
Aventis Pharmaceuticals Inc. Operating Company
Represented By
3 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Plaintiff
Sanofi-Aventis US LLC Operating Company
Represented By
3 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Counter Claimant
Barr Laboratories Inc. Operating Company
Represented By
3 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Shaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 20 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 5,976,573 A Asserted | US Continuation / Sibling | View Official Patent → |
| πͺπΊ European Patent Office (UPC States) | EP 3,077,914 A | European Counterpart (EP) | View Official Patent → |
| πͺπΊ European Patent Office (UPC States) | EP 1,382,330 A1 | European Counterpart (EP) | View Official Patent → |
| π―π΅ Japan | JP 10504409 A | Japan Counterpart | View Official Patent → |
| π―π΅ Japan | JP 2001501914 A | Japan Counterpart | View Official Patent → |
| π PCT International (WIPO) | WO 1998000178 A1 | PCT World Application | View Official Patent → |
| π©πͺ Germany | DE 69725161 T | Germany Counterpart | View Official Patent → |
| πͺπΊ European Patent Office (UPC States) | EP 97,933,237 A | European Counterpart (EP) | View Official Patent → |
| πͺπΊ European Patent Office (UPC States) | EP 938,345 B1 | European Counterpart (EP) | View Official Patent → |
| π¨π³ China | CN 1235568 C | China Counterpart | View Official Patent → |
| π°π· South Korea | KR 100383601 B1 | South Korea Counterpart | View Official Patent → |
| π¨π¦ Canada | CA 002268927 A | Canada Counterpart | View Official Patent → |
| π¨π¦ Canada | CA 2268927 C | Canada Counterpart | View Official Patent → |
| πΊπΈ United States | US 6,143,329 A | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 6,375,984 B1 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5976573
Aqueous-based pharmaceutical composition
|
Filed: 1996-07-03
Issued: 1999-11-02
|
Expired (Term Ended)
Expires: 2016-07-03
|
|
|
US6143329
Aqueous-based pharmaceutical composition
|
Filed: 1999-05-20
Issued: 2000-11-07
|
Expired (Term Ended)
Expires: 2019-05-20
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
8
Dispositive
8
Granted
0
Denied
0
Pending / Review
8
Motions by Category
Key Dispositive Motions & Rulings